Men who have undergone radical prostatectomy or curative pelvic surgery for prostate cancer frequently experience erectile dysfunction as a consequence of treatment. Structured penile rehabilitation initiated promptly after surgery is central to managing this condition.
This protocol targets patients with a history of radical prostatectomy or curative pelvic surgery for prostate cancer. PDE5 inhibitors are recognised as first-line therapy in patients who have undergone nerve-sparing surgery, regardless of the specific surgical technique used. Early initiation of pro-erectile treatment — starting at the earliest opportunity after surgery — is the guiding principle.
The protocol involves early-start oral therapy from a specific inhibitor class, supported by evidence from a large network of rehabilitation trials. Combination approaches incorporating a mechanical device are also addressed. The complete regimen — including sequencing, specific options, and supporting evidence — is available in the full protocol.
Recovery of erectile function sufficient for satisfactory intercourse.